LakeShore Biopharma Co., Ltd. (LSBCF) › Capital ExpendituresLakeShore Biopharma Co., Ltd. (LSBCF) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2021: 104.88M CNY2022: 295.31M CNY2023: 52.76M CNY2024: 44.25M CNY2025: 12.71M CNY12.71M CNY2021Capital Expenditures (CNY)2025Fiscal YearCapital ExpendituresChange YoY202512.71M CNY-71.3%202444.25M CNY-16.1%202352.76M CNY-82.1%2022295.31M CNY+181.6%2021104.88M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share